Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ER membrane protein complex subunit 6 (EMC6, also known as TMEM93) is a core component of the endoplasmic reticulum (ER) membrane protein complex (EMC), a multi-subunit machinery essential for the insertion and biogenesis of membrane proteins, particularly those with multiple or tail-anchored transmembrane domains. EMC6, together with EMC3, forms the core insertase module of the EMC and is highly conserved across species. In animals, EMC6 is necessary for correct trafficking, folding, and localization of crucial membrane proteins such as rhodopsin in photoreceptors, and its deletion leads to photoreceptor degeneration, abnormal cilia formation, and impaired protein transport. It is also implicated in cellular autophagy regulation and has been associated with apoptotic and inflammatory processes in specific tissues, but is not directly recognized as a therapeutic drug target at present.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ER membrane protein complex subunit 6 (EMC6).